Connect with us

Press Release

Innovative Wet Etching Technology Achieves 0.005mm Precision for Stainless Steel Fabrication

Published

on

China, 7th Apr 2025, – New advancements in stainless steel wet etching technology deliver unmatched precision (±0.005mm), enhanced production efficiency, and eco-friendly solutions. The system reduces operational costs while meeting stringent environmental standards, with applications spanning electronics, medical devices, and architectural design.

Technical Advancements Redefine Precision Standards
Stainless steel etching technology has evolved significantly since its inception, transitioning from manual chemical engraving to advanced automated systems. Traditional methods, such as dry etching and laser cutting, often face challenges in maintaining consistency and minimizing material stress. Wet etching, a chemical dissolution process, now emerges as a superior alternative, achieving precision levels of ±0.005mm—surpassing conventional techniques in accuracy and repeatability.
 

Innovative Wet Etching Technology Achieves 0.005mm Precision for Stainless Steel Fabrication
 

Modern wet etching machines integrate high-resolution masking systems and optimized chemical formulations, enabling intricate patterns on stainless steel substrates. Unlike laser-based methods, which risk thermal deformation, wet etching stainless steel preserves material integrity while supporting complex geometries. Industry analysts note its growing adoption in microelectronics and precision engineering, where sub-millimeter tolerances are critical.

Future developments aim to incorporate AI-driven process controls and robotic automation, further enhancing precision and scalability. Researchers predict these innovations will reduce human intervention by 40% while accelerating production cycles.

Efficiency and Cost-Effectiveness
Wet etching systems demonstrate marked improvements in resource utilization, reducing raw material waste by up to 30% compared to mechanical cutting. Automated chemical dosing and recycling mechanisms minimize reagent consumption, lowering operational costs. A streamlined workflow shortens processing times by 25%, enabling high-volume output without compromising quality.

Traditional methods incur higher energy expenditures due to prolonged machining cycles and frequent tool replacements. In contrast, wet etching equipment operates at ambient temperatures, slashing energy use by approximately 20%. Maintenance costs are similarly reduced, with self-cleaning modules extending system longevity.

Environmental Compliance and Sustainability
As global environmental regulations tighten, wet etching technology addresses sustainability challenges. Closed-loop chemical management systems reduce solvent usage by 35%, while advanced filtration ensures wastewater meets ISO 14001 discharge standards. The process eliminates hazardous byproducts associated with plasma etching, aligning with EU REACH and U.S. EPA guidelines.

Industry leaders emphasize its role in circular manufacturing. “Our systems enable 95% chemical recovery rates, significantly reducing ecological footprints,” notes a senior engineer involved in R&D.

Diverse Applications and Market Success
Wet etching’s versatility supports applications across industries:

  • Electronics: Micro-components for circuit boards and sensors.
     
  • Medical: Surgical tools and implantable devices requiring biocompatible finishes.
  • Architecture: Decorative panels with micron-level detailing.

A leading European medical device manufacturer recently adopted wet etching to produce coronary stents, citing 50% faster turnaround times. Similarly, a Japanese electronics firm achieved zero defect rates in microelectrode production after transitioning to the technology. Customizable parameters allow adaptation to varied material grades, including 316L and 430 stainless steel.

Industry Endorsements and Future Vision
The technology has garnered recognition from institutions like the International Journal of Advanced Manufacturing, which praised its “transformative potential in precision engineering.” Awards such as the Global Manufacturing Innovation Prize underscore its market impact.

Dr. Elena Torres, a materials science expert, states, “Wet etching bridges the gap between mass production and artisanal precision—a critical leap for Industry 4.0.”

Looking ahead, developers aim to integrate IoT-enabled predictive maintenance and hybrid etching techniques. “Our next-gen systems will leverage machine learning to self-optimize in real time,” reveals a project lead at [Company Name].

Media Contact

Organization: Shenzhen Xinxin Precision Equipment Co., Ltd.

Contact
Person:
Nigen Xiao

Website:

Custom Chemical Etching

Email:

Custom Chemical Etching

Country:China

The post Innovative Wet Etching Technology Achieves 0.005mm Precision for Stainless Steel Fabrication appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Top KOL Zhang Meng Boosts Overseas Brands to Viral Status on RED Note (Xiaohongshu), Helping Overseas Chinese IPs Break Through

Published

on

Top KOL Paves the Way for Niche Brands’ “First Stop in China”

The emerging social platform RED (Xiaohongshu), with 600 million daily searches, has risen as the most popular “super traffic gateway” among Chinese youth. As globalization accelerates, it topped the download charts for social apps in the U.S., Canada, and the UK in January 2025 and ranked among the top 10 lifestyle apps in Southeast Asia, including Japan and South Korea, becoming a bridge connecting Chinese and global consumers.

From Overseas Chinese Incubation to Brand Pioneer: Top KOL Zhang Meng Opens the First Stop for Niche Brands Entering China

Zhang Meng, a Harvard Business School alumna, leveraged her cross-cultural expertise and business acumen to seize this opportunity. Since 2023, she has focused on operating her RED (Xiaohongshu) account, rapidly evolving from an emerging influencer to a top KOL.Her efforts have successfully helped numerous overseas niche brands enter and thrive in the Chinese market.

With 12 years of entrepreneurial experience and multiple startups under her belt, Zhang Meng excels at identifying differences between Chinese and international consumer markets. She swiftly adapts brand positioning and capitalizes on audience engagement,making her a key facilitator for overseas brands entering China. Recognized for her outstanding performance and industry influence, Zhang Meng was named one of RED (Xiaohongshu)’s “Top 100 KOLs of 2024” and ranked among the top 10 live-streaming hosts during China’s 618 Shopping Festival. She is the trusted “First Stop in China” for niche global brands.

Under her guidance, brands from dozens of countries have successfully penetrated the Chinese market, including:

Canada: Probaclac, Organika, LOEON, Flora

USA: Nutrafol, Nature’s Answer, Orgain, Multipure, Micro Ingredients

Spain: Bechi, Eladiet, Plameca

UK: Templespa, Optibac

Germany: Stada

Austria: Tomorrowlabs

France: LYSEDIA, D-Lab, Olioseptil, IOMA

Portugal: Amalia Home Collection

Japan: Bmark

Singapore: Fibro

New Zealand: Mitoq, Phatma

Australia: Unichi, Inner Health

Italy: ZUCCARI

Finland: Hyllers

Zhang Meng helps brands transcend geographical and cultural barriers. For overseas brands unfamiliar with the Chinese market, she builds bridges to local consumers by aligning product values with Chinese consumer preferences. She pioneered a unique “Knowledge-Based KOL” model, combining product introductions, educational content, and lifestyle storytelling. As she advocates, “Live-streaming commerce isn’t just a sales channel—it’s a content-centric approach that builds emotional connections and elevates brand value that fosters emotional connections and elevates brand value.” This long-term vision has made her a benchmark figure on RED (Xiaohongshu), where she consistently ranks as the leading cross-border KOL on the platform.

Empowering Overseas Chinese IPs to Monetize Their Influence

After achieving success as a top KOL, Zhang Meng—a veteran in the education and training industry—systematized her journey from novice to expert. She developed a step-by-step framework for building personal IPs from scratch, mentoring individuals across niches. Her trainees include not only domestic creators but also overseas Chinese professionals, such as:

International finance experts

Cross-cultural couples offering language training

High-net-worth consultants for overseas real estate

Study-abroad advisors

Expat moms sharing local life hacks

By merging their knowledge, skills, and unique experiences with market demand, Zhang Meng transforms these individuals into distinctive social media influencers. Under her guidance, they master RED (Xiaohongshu) live-streaming and ad monetization, achieving both financial gains and brand growth.

Bridging Global Business Exchange

Zhang Meng’s entrepreneurial journey began in college when she attended the APEC CEO Summit, marking her debut on the international stage. Her insights into youth trends and startup ecosystems led to meetings with 30+ global leaders, including former UK Prime Minister David Cameron and former U.S. Secretary of State Hillary Clinton. She facilitated Sino-global business dialogue, fostering cross-cultural understanding.

Her global expeditions took her to brand origins and supply chain hubs. In 2015, she joined the China-France Young Leaders Forum, fostering collaboration between entrepreneurs from both nations. She has also spoken at elite forums like the Boao Forum for Asia, Davos World Economic Forum, and G20 Summit, earning titles such as:

“Global Young Leader” (Boao Forum)

“Asia’s Rising Pioneer” (Tatler Magazine)

“Global Shaper” (World Economic Forum)

The 300 Million-Person Miracle: From Time Management to Startup Mentorship

A serial entrepreneur, Zhang Meng designs practical courses on innovation and business, covering fundamentals, personal growth, and operational strategies. Her programs have empowered 15 million Chinese youth to start their ventures. She champions early rising, reading, and efficiency, sparking the viral hashtag #RiseWithMengJie# (3.4 billion views on Weibo).

Her books, including the bestseller *The Efficiency Manual* (over 1 million copies sold), distill her methods for time management, productivity, and self-improvement. Recognized as a Youth Entrepreneurship Mentor by China’s Ministry of Human Resources and a lecturer at Peking University, HKU, and Beijing Normal University, she blends theory with real-world practice.

Her contributions have earned her national honors like:

National March 8th Red-Banner Holder (top accolade for Chinese women)

Beijing Model Worker

Beijing May 4th Youth Medal

From Boxing Ring to Boardroom: The Multifaceted “Iron Meng”

In China’s fast-evolving business landscape, Zhang Meng has repeatedly pivoted successfully—from brick-and-mortar chains to knowledge-based paid content and live-streaming economies. Her adaptability mirrors her cross-domain grit as a professional boxer. In 2023, she made history as China’s first female crossover athlete in the WBA Asia Championship, ranking #1 in China and #61 globally (BoxRec). Dubbed “Iron Meng,” she embodies the ethos: “Life knows no limits—excel to achieve greatness.”

In 2025, Zhang Meng returned from Harvard Business School armed with cutting-edge strategies, ready to redefine how global brands connect with China. Her story inspires a new generation of leaders to drive cultural and commercial synergy worldwide.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Letters from Gilgil 3 by Peter Massam Receives Accolades

Published

on

Letters from Gilgil 3 (The Letters from Gilgil series)

United Kingdom, 25th Jun 2025, – Acclaimed author Peter Massam returns with Letters from Gilgil 3, the final and most introspective volume in his celebrated travel memoir trilogy. Recently honored with the BREW Seal of Excellence and the Book World Front Award, this conclusion is already being hailed as a “literary landmark in ecological and cultural nonfiction.”

“If volume one was the warm-up, and volume two the crescendo, this final entry is the exhale,” writes The Chrysalis BREW Project. “A symphony played not on instruments, but on altitude, resilience, and the red volcanic soil of Kenya’s hidden roads.”

Structured around letters written during a teaching placement in 1980s Kenya, Letters from Gilgil 3 recounts Massam’s most ambitious journeys: a starlit climb up Mount Kenya to witness Halley’s Comet; a trek into Turkana’s lava fields; a final, slow safari through lands on the cusp of change. 

Massam combines evocative storytelling with real science and anthropology. Readers will learn how obsidian shards tell geological stories, why fossilized Nile perch bones matter, and how tribal customs can teach resilience and grace. 

“Massam doesn’t write to impress,” notes OneTribune Media. “He writes to preserve. And he invites us not to spectate, but to witness.”

“Each book in this trilogy is a compass,” states The Chrysalis BREW Project. “Together, they form a cartography of grace.”

Available Now

Letters from Gilgil 3 is available in print and digital formats through major booksellers. A collector’s edition of the full Letters from Gilgil trilogy, including restored slides and new author annotations, is planned for early 2026. 

About the Author

Peter Massam is a British author and educator whose works span poetry, technical writing, and narrative nonfiction. Known for his vivid yet modest prose, he is the author of the Cuz Collection, Learning Experience trilogy, and multiple award-winning books about travel, nature, and memory.

For more information about Peter Massam or to get a copy of his books, visit his Amazon author page.

 

Media Contact

Organization: Author of Letters from Gilgil 3

Contact
Person:
Peter Massam

Website:


Email:

pwmassam@gmail.com

Country:United Kingdom

The post
Letters from Gilgil 3 by Peter Massam Receives Accolades
appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange

Published

on

SHENZHEN, CHINA The board of directors of China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group”) announces the proposed secondary listing of the Company’s ordinary shares (“Shares”) on the Singapore Exchange Securities Trading Limited (the “SGX-ST”) by way of introduction (the “Proposed Secondary Listing”). The Proposed Secondary Listing, if proceeded, will not involve issuance of new shares, and the Shares will continue to be primarily listed and traded on the Hong Kong Stock Exchange thereafter.

The Company has submitted, on a confidential basis, an application to the SGX-ST in relation to the Proposed Secondary Listing. As of the date of this announcement, the Company has not received the eligibility-to-list letter (“ETL”) from the SGX-ST in respect of the Proposed Secondary Listing.

On June 24, 2025, the Company received the Notice of Overseas Issuance and Listing Filing from the China Securities Regulatory Commission (the “CSRC”) in respect of the Proposed Secondary Listing.

The Directors believe that upon completion of the proposed secondary listing on the SGX-ST, the Group will be able to attract funds focusing on Asia-Pacific investments and local capital in Southeast Asia, thereby optimizing the shareholder structure. At the same time, it will also have a more profound impact on the Group’s business development in Southeast Asia and the Middle East. The Group has established Singapore as its regional headquarters for its Southeast Asia and Middle East business, and has set up companies in Singapore covering the entire pharmaceutical value chain of R&D, manufacturing, commercialization and investment, including CMS R&D as the international independent R&D company, PharmaGend as the pharmaceutical manufacturing CMO/CDMO company, Rxilient as the pharmaceutical development, registration and commercialization company, and Singapore Venture Capital as the industrial investment company. These companies work together to provide Southeast Asian patients with more high-quality and affordable treatment options, contribute to the development of the pharmaceutical industry chain in Southeast Asia, enhance the Group’s global reputation and market position, promote the implementation of the Group’s “Glocalization” strategy, and bring additional growth to the Group.

The Company will make further announcements with respect to the Proposed Secondary Listing as and when necessary in compliance with the applicable laws and regulations.

The Proposed Secondary Listing is subject to the SGX-ST granting an ETL and the fulfilment of any conditions set out in the ETL. As such, there is no assurance that the Proposed Secondary Listing will proceed to completion. Shareholders and potential investors of the Company are advised to exercise caution when dealing in the securities of the Company.

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its skin health and ophthalmology businesses, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group.

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

Source: China Medical System Holdings Ltd.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST